Elevated angiogenin levels in chronic heart failure

Annals of Medicine

Volumn 40, Issue 6, 2008, Pages 474-479

  Patel, Jeetesh V ^b   Sosin, Michael ^b   Gunarathne, Ashan ^b   Hussain, Imran ^b   Davis, Russell C ^b   Hughes, Elizabeth A ^b   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

Angiogenesis; Brain natriuretic peptide; Diabetes; Inflammation

Indexed keywords

ANGIOGENIN; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RIBONUCLEASE, PANCREATIC; SEVERITY OF ILLNESS INDEX;

EID: 50649094894     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890802001419     Document Type: Article

References (17)

1. McMurray JJ, Stewart S. Epidemiology, aetiology and prognosis of heart failure. Heart. 2000;83:596-602.
2. Vasan RS. Biomarkers of Cardiovascular Disease: molecular basis and practical considerations. Circulation. 2006;11:2335-62.
3. Felmeden DC, Blann AD, Lip GYH. Angiogenesis: basic pathophysiology and implications for disease. Eur Heart J. 2003;24:586-603.
4. Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. J Am Coll Cardiol. 2004;43:423-8.
5. Chong AY, Caine GJ, Lip GY. Angiopoietin/tie-2 as mediators of angiogenesis: a role in congestive heart failure? Eur J Clin Invest. 2004;34:9-13.
6. Chin BS, Blann AD, Gibbs CR, Chung NA, Conway DG, Lip GY. Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure. Eur J Clin Invest. 2003;33:941-8.
7. Chin BS, Chung NA, Gibbs CR, Blann AD, Lip GY. Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. Am J Cardiol. 2002;90:1258-60.
8. Tello-Montoliu A, Patel JV, Lip GYH. Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost. 2006;4:1864-74.
9. Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond). 2005;29:1308-14.
10. Burgmann H, Hollenstein U, Maca T, Zedwitz-Liebenstein K, Thalhammer F, Koppensteiner R, et al. Increased serum laminin and angiogenin concentrations in patients with peripheralarterial occlusive disease. J Clin Pathol. 1996;49:508-10.
11. Tello-Montoliu A, Marin F, Patel J, Mainar L, Roldan V, Chung I, et al. Prognostic role of plasma angiogenin in non-ST-elevation acute coronary syndrome. Eur Heart J. 2007;28:3006-11.
12. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-40.
13. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, Mass: Little Brown & Co Inc; 1994.
14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-67.
15. Pearlman JD, Hibberd MG, Chuang ML. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med. 1995;1:1085-9.
16. Lim HS, Blann AD, Chong AY, Freestone B, Lip GYH. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care. 2004;27:2918-24.
17. Opie LH. The metabolic vicious cycle in heart failure. Lancet. 2004;364:1733-4.